Investigator

Sabrina Chan

Research Project Manager · Dana-Farber Cancer Institute, Oncologic Pathology

SCSabrina Chan
Papers(1)
Multimodal Spatial Pr…
Collaborators(10)
Sandro SantagataSarah H. KimShannon CoyStefan M. GyslerTanjina KaderYilin XuYu-An ChenBaby A. SatravadaCharles W. DrescherClarence Yapp
Institutions(5)
Unknown InstitutionBrigham and Women's H…University Of Pennsyl…Sloan Kettering Insti…Fred Hutchinson Cance…

Papers

Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma

Abstract High-grade serous ovarian cancer (HGSOC) originates from fallopian tube (FT) precursors. However, the molecular changes that occur as precancerous lesions progress to HGSOC are not well understood. To address this, we integrated high-plex imaging and spatial transcriptomics to analyze human tissue samples at different stages of HGSOC development, including p53 signatures, serous tubal intraepithelial carcinomas (STIC), and invasive HGSOC. Our findings reveal immune modulating mechanisms within precursor epithelium, characterized by chromosomal instability, persistent IFN signaling, and dysregulated innate and adaptive immunity. FT precursors display elevated expression of MHC class I, including HLA-E, and IFN-stimulated genes, typically linked to later-stage tumorigenesis. These molecular alterations coincide with progressive shifts in the tumor microenvironment, transitioning from immune surveillance in early STICs to immune suppression in advanced STICs and cancer. These insights identify potential biomarkers and therapeutic targets for HGSOC interception and clarify the molecular transitions from precancer to cancer. Significance: This study maps the immune response in FT precursors of HGSOC, highlighting localized IFN signaling, chromosomal instability, and competing immune surveillance and suppression along the progression axis. It provides an explorable public spatial profiling atlas for investigating precancer mechanisms, biomarkers, and early detection and interception strategies. See related commentary by Recouvreux and Orsulic, p. 1093

1Papers
28Collaborators
Biomarkers, TumorNeoplasmsObsessive-Compulsive DisorderTumor MicroenvironmentOvarian NeoplasmsCystadenocarcinoma, Serous

Positions

2022–

Research Project Manager

Dana-Farber Cancer Institute · Oncologic Pathology

2022–

Research Project Manager

Harvard Medical School · Laboratory of Systems Pharmacology

2019–

Clinical Research Coordinator

Massachusetts General Hospital · Psychiatry

Education

Bachelor's of Science

Northeastern University